The Genentech medicines supported by the Genentech Patient Foundation are:
Actemra® (tocilizumab)
Activase® (alteplase)
Alecensa® (alectinib)
Avastin® (bevacizumab)
Cathflo Activase® (alteplase)
Cotellic® (cobimetinib)
Enspryng™ (satralizumab-mwge)
Erivedge® (vismodegib)
Esbriet® (pirfenidone)
Evrysdi™ (risdiplam)
Gazyva® (obinutuzumab)
Gavreto™ (Pralsetinib)
Hemlibra® (emicizumab-kxwh)
Herceptin® (trastuzumab)
Herceptin Hylecta™ (trastuzumab and hyaluronidase-oysk)
Kadcyla® (ado-trastuzumab emtansine)
Lucentis™ (ranibizumab injection)
LUNSUMIO™ (mosunetuzumab-axgb)
Ocrevus® (ocrelizumab)
Perjeta® (pertuzumab)
Phesgo™ (pertuzumab, trastuzumab, and hyaluronidase-zzxf)
Polivy™ (polatuzumab vedotin-piiq)
Pulmozyme® (dornase alfa)
Rituxan® (rituximab)
Rituxan Hycela™ (rituximab and hyaluronidase human)
Rozlytrek™ (entrectinib)
Susvimo™ (ranibizumab injection)
Tecentriq® (atezolizumab)
TNKase® (tenecteplase)
Vabysmo™ (faricimab)
Venclexta® (venetoclax)
Xolair® (omalizumab)
Zelboraf® (vemurafenib)
Please Note: At this time, the Genentech Patient Foundation uses a separate process to support the following medicines:
CELLCEPT® (mycophenolate mofetil)
FUZEON® (enfuvirtide)
NUTROPIN AQ® (somatropin)
VALCYTE® (valganciclovir hydrochloride)
Learn more about support programs for these Genentech medicines here.
If you have been prescribed a participating medicine, you may qualify for support from the Genentech Patient Foundation. View the 'See If You Qualify' page to determine eligibility.
Support for Genentech medicines not listed above:
If you do not see your medicine listed, please contact our Patient Resource Center at 1 (877) GENENTECH (436-3683) for more information.
Request medicines on the Prescriber Foundation Form. This must be completed by a health care provider. Download the form by clicking here.
Patient Consent Form
The Patient Consent form must also be submitted to apply for help. This must be completed by a patient or their legally authorized person. Download the Patient Consent form by clicking here.